Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
In the entertainment industry, we frequently see private placement memoranda seeking to raise capital for films and that refer to success stories such as My Big Fat Greek Wedding , Little Miss Sunshine or other independent films that became box office hits. But the U.S. Supreme Court's March 24, 2015, decision in Omnicare Inc. v. Laborers District Counsel Construction Industry Pension Fund, 13'435, should make all producers think twice about whether, or how, to include these success stories.
In the Omnicare case, in a registration statement the defendant had included opinions that it was legally complying with laws regarding its business practices of accepting rebates from drug companies in connection with its business of providing pharmacy services for residents of nursing homes. Even though Omnicare noted in the registration statement ' near its statements of belief that it was legally compliant ' that state and federal enforcement actions could adversely affect its business, the Supreme Court found a potential violation of '11 of the 1933 Securities Act: there was an issue for trial about whether Omnicare could hold a reasonable belief that it was legally compliant in light of such federal and state enforcement actions. The Supreme Court therefore reversed a decision by the U.S. Court of Appeals for the Sixth Circuit in favor of Omnicare and sent the case back for further proceedings.
So what do drug company kickbacks have to do with successful independent films?
The heart of the Supreme Court decision is in Section III of its opinion in which it quotes language from the 1933 Act's '11, finding potential liability if the issuer “'omitted to state facts necessary' to make its opinion on legal compliance 'not misleading.'” In effect, the Supreme Court is getting into the murky area of what is a reasonable basis for having a belief.
Given widespread industry knowledge in the film industry about the number of independent films that fail to return investments to the film's investors, this case suggests that a film producer, in a private placement memo, could face securities law liability if, when discussing the success of recent independent films, the producer does not also include information about films which are less successful or a complete failure.
These discussions can take any number of different forms, depending on how the private placement memo discusses the “success” stories. The Supreme Court's Omnicare decision, however, is a warning to film producers using private placement memos (or Internet-based offering documents seeking accredited investors, which is now permitted under Title II of the JOBS Act and related SEC regulations) that examples of independent film successes in a private placement memo are no longer just puffery.
Thomas D. Selz is a founder of the New York City law firm Frankfurt Kurnit Klein & Selz PC (www.fkks.com). His entertainment practice includes advising on film, TV, live stage productions, publishing and sound recordings.
In the entertainment industry, we frequently see private placement memoranda seeking to raise capital for films and that refer to success stories such as My Big Fat Greek Wedding , Little Miss Sunshine or other independent films that became box office hits. But the U.S. Supreme Court's March 24, 2015, decision in
In the Omnicare case, in a registration statement the defendant had included opinions that it was legally complying with laws regarding its business practices of accepting rebates from drug companies in connection with its business of providing pharmacy services for residents of nursing homes. Even though Omnicare noted in the registration statement ' near its statements of belief that it was legally compliant ' that state and federal enforcement actions could adversely affect its business, the Supreme Court found a potential violation of '11 of the 1933 Securities Act: there was an issue for trial about whether Omnicare could hold a reasonable belief that it was legally compliant in light of such federal and state enforcement actions. The Supreme Court therefore reversed a decision by the U.S. Court of Appeals for the Sixth Circuit in favor of Omnicare and sent the case back for further proceedings.
So what do drug company kickbacks have to do with successful independent films?
The heart of the Supreme Court decision is in Section III of its opinion in which it quotes language from the 1933 Act's '11, finding potential liability if the issuer “'omitted to state facts necessary' to make its opinion on legal compliance 'not misleading.'” In effect, the Supreme Court is getting into the murky area of what is a reasonable basis for having a belief.
Given widespread industry knowledge in the film industry about the number of independent films that fail to return investments to the film's investors, this case suggests that a film producer, in a private placement memo, could face securities law liability if, when discussing the success of recent independent films, the producer does not also include information about films which are less successful or a complete failure.
These discussions can take any number of different forms, depending on how the private placement memo discusses the “success” stories. The Supreme Court's Omnicare decision, however, is a warning to film producers using private placement memos (or Internet-based offering documents seeking accredited investors, which is now permitted under Title II of the JOBS Act and related SEC regulations) that examples of independent film successes in a private placement memo are no longer just puffery.
Thomas D. Selz is a founder of the
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
GenAI's ability to produce highly sophisticated and convincing content at a fraction of the previous cost has raised fears that it could amplify misinformation. The dissemination of fake audio, images and text could reshape how voters perceive candidates and parties. Businesses, too, face challenges in managing their reputations and navigating this new terrain of manipulated content.
What Law Firms Need to Know Before Trusting AI Systems with Confidential Information In a profession where confidentiality is paramount, failing to address AI security concerns could have disastrous consequences. It is vital that law firms and those in related industries ask the right questions about AI security to protect their clients and their reputation.
The International Trade Commission is empowered to block the importation into the United States of products that infringe U.S. intellectual property rights, In the past, the ITC generally instituted investigations without questioning the importation allegations in the complaint, however in several recent cases, the ITC declined to institute an investigation as to certain proposed respondents due to inadequate pleading of importation.
As the relationship between in-house and outside counsel continues to evolve, lawyers must continue to foster a client-first mindset, offer business-focused solutions, and embrace technology that helps deliver work faster and more efficiently.
As consumers continue to shift purchasing and consumption habits in the aftermath of the pandemic, manufacturers are increasingly reliant on third-party logistics and warehousing to ensure their products timely reach the market.